Cargando…

Bioavailability of Orally Administered Drugs in Critically Ill Patients

Critically ill patients managed in the Intensive Care Unit (ICU) suffer from several pathophysiological alterations due to critical illness resulting in potential changes in the pharmacokinetics of drugs including systemic absorption. Nevertheless, these patients are still given some medications in...

Descripción completa

Detalles Bibliográficos
Autores principales: Forsberg, Johanna, Bedard, Emma, Mahmoud, Sherif H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350721/
https://www.ncbi.nlm.nih.gov/pubmed/35521821
http://dx.doi.org/10.1177/08971900221100205
_version_ 1785074203946385408
author Forsberg, Johanna
Bedard, Emma
Mahmoud, Sherif H.
author_facet Forsberg, Johanna
Bedard, Emma
Mahmoud, Sherif H.
author_sort Forsberg, Johanna
collection PubMed
description Critically ill patients managed in the Intensive Care Unit (ICU) suffer from several pathophysiological alterations due to critical illness resulting in potential changes in the pharmacokinetics of drugs including systemic absorption. Nevertheless, these patients are still given some medications in unadjusted doses thereby putting the patients at a risk for therapy failure. The objective for this study was to summarize the available evidence regarding oral drug absorption in the ICU. A literature search of the databases MEDLINE, EMBASE, and PubMed was conducted on (February 24, 2020). Articles discussing the rate and/or extent of orally administered drugs in critically ill patients were included. A total of 58 studies were found: 17 interventional studies, 33 observational studies (30 prospective, 3 retrospective) and 8 case reports. A total of 43 articles reported altered drug absorption in critically ill patients suggesting the need for alternative measures to facilitate treatment success. The absorption of orally administered drugs may be altered in critically ill patients. Measures for altered drug absorption in critically ill patients were suggested such as holding tube feeding before and after medication administration, increasing doses of orally administrated drugs and using alternate routes of administration.
format Online
Article
Text
id pubmed-10350721
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-103507212023-07-18 Bioavailability of Orally Administered Drugs in Critically Ill Patients Forsberg, Johanna Bedard, Emma Mahmoud, Sherif H. J Pharm Pract Review Articles Critically ill patients managed in the Intensive Care Unit (ICU) suffer from several pathophysiological alterations due to critical illness resulting in potential changes in the pharmacokinetics of drugs including systemic absorption. Nevertheless, these patients are still given some medications in unadjusted doses thereby putting the patients at a risk for therapy failure. The objective for this study was to summarize the available evidence regarding oral drug absorption in the ICU. A literature search of the databases MEDLINE, EMBASE, and PubMed was conducted on (February 24, 2020). Articles discussing the rate and/or extent of orally administered drugs in critically ill patients were included. A total of 58 studies were found: 17 interventional studies, 33 observational studies (30 prospective, 3 retrospective) and 8 case reports. A total of 43 articles reported altered drug absorption in critically ill patients suggesting the need for alternative measures to facilitate treatment success. The absorption of orally administered drugs may be altered in critically ill patients. Measures for altered drug absorption in critically ill patients were suggested such as holding tube feeding before and after medication administration, increasing doses of orally administrated drugs and using alternate routes of administration. SAGE Publications 2022-05-06 2023-08 /pmc/articles/PMC10350721/ /pubmed/35521821 http://dx.doi.org/10.1177/08971900221100205 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Review Articles
Forsberg, Johanna
Bedard, Emma
Mahmoud, Sherif H.
Bioavailability of Orally Administered Drugs in Critically Ill Patients
title Bioavailability of Orally Administered Drugs in Critically Ill Patients
title_full Bioavailability of Orally Administered Drugs in Critically Ill Patients
title_fullStr Bioavailability of Orally Administered Drugs in Critically Ill Patients
title_full_unstemmed Bioavailability of Orally Administered Drugs in Critically Ill Patients
title_short Bioavailability of Orally Administered Drugs in Critically Ill Patients
title_sort bioavailability of orally administered drugs in critically ill patients
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350721/
https://www.ncbi.nlm.nih.gov/pubmed/35521821
http://dx.doi.org/10.1177/08971900221100205
work_keys_str_mv AT forsbergjohanna bioavailabilityoforallyadministereddrugsincriticallyillpatients
AT bedardemma bioavailabilityoforallyadministereddrugsincriticallyillpatients
AT mahmoudsherifh bioavailabilityoforallyadministereddrugsincriticallyillpatients